Predictive factors and therapeutic approach of renovascular disease: Four years' follow-up

Renal Failure

Volumn 30, Issue 10, 2008, Pages 965-970

  Ziakka, Stavroula ^a   Ursu, Michaela ^a   Poulikakos, Dimitris ^a   Papadopoulos, Christophoros ^a   Karakasis, Filippos ^a   Kaperonis, Nikolaos ^a   Papagalanis, Nicolas ^a,b  

^a Nephrology Department   (Greece)

^b NONE   (Greece)

Author keywords

Atheromatous renal artery stenosis; Blood pressure; Eosinophil count; Oxidative stress; Renal function; Stent placement

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE EXACERBATION; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; STENT; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANGIOPLASTY; ATHEROSCLEROSIS; BLOOD PRESSURE; DISEASE PROGRESSION; EOSINOPHILIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENOVASCULAR; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; REACTIVE OXYGEN SPECIES; STENTS; TREATMENT OUTCOME;

EID: 57049100434     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802389334     Document Type: Article

References (30)

1. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, et al. Renal artery stenosis: Prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2:1608-1616.
2. Van Ampting JMA, Penne EL, Beek FJ, Koomans HA, Boer WH, Beutler JJ. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant. 2003;18:1147-1151.
3. Losito A, Fagugli RM, Zampi I,Parente B, de Rango P, Giordano G, et al. Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens. 1996;9:1062-1067.
4. Webster J, Marshall F, Abdalla M, Dominiczac A, Edwards R, Isles CG, et al. Randomized comparison angioplasty vs. continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Human Hypertens. 1998;12:329-335.
5. Plouin PF, Chatellier G, Darnè B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial. Hypertension. 1998;31:823-829.
6. Van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Denium J, Postma CT, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007-1014.
7. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med. 2003;114:44-50.
8. Ives N, Wheatley K, Stowe RL, Krijnen P, Plouin PF, van Jaarsveld BC, et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: A meta-analysis of randomized trials. Nephrol Dial Transplant. 2003;18:298-304.
9. Harden PN, MacLeod MJ, Rodger RSC, Baxter GM, Connel JM, Dominiczac AF, et al. Effect of renal artery stenting on progression of renovascular renal failure. Lancet. 1997;349:1133-1136.
10. Webster J, Marshall F, Abdalla M, Dominiczac A, Edwards R, Isles CG, et al. Randomised comparison of percutaneous angioplasty vs. continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens. 1998;12:329-335.
11. Van Jaarsveld, Krijnen P, Pieterman H, Derkx FH, Deinum J, Posma CT, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N Engl J Med. 2000;342:1007-1014.
12. Siddiqui S, MacGregor MS, Glynn C, Roditi G, Deighan C. Factors predicting in a cohort of patients with atherosclerotic renal artery disease diagnosed by magnetic resonance angiography. Am J Kidney Dis. 2005;46:1065-1073.
13. Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A. Free radicals, mitochondria, and oxidized lipids: The emerging role in signal transduction in vascular cells. Circ Res. 2006;99:924-932.
14. Usberti M, Gerardi G, Bufano G,Tira P, Micheli A, Albertini A, et al. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis. 2002;40:590-599.
15. Gerardi GM, Usberti M, Martini G, Albertini A, Sugherini L, Pompella A, et al. Plasma total antioxidant capacity in hemodialyzed patients and its relationship to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med. 2002;40:104-110.
16. Pickering TG, Herman L, Devereux RB, Sotelo JE, James GD, Sos TA, et al. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet.1988;2:551-552.
17. Missouris CG, Buckenham T, Vallance PJT, MacGregor GA. Renal artery stenosis masquerading as congestive heart failure. Lancet. 1993;341:1521-1522.
18. Missouris CG, Belli AM, MacGregor GA. Apparent heart failure: A syndrome caused by renal artery stenosis. Heart. 2000;83:152-155.
19. Ramos F, Kotliar C, Alvarez D, Baglivo H, Rafaelle P, Londero H, et al. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int. 2003;63:276-282.
20. Hanzel G, Balon H, Wong O, Soffer D, Lee DT, Safian RD. Prospective evaluation of aggressive medical therapy for atherosclerotic renal artery stenosis, with renal artery stenting reserved for previously injured heart, brain, or kidney. Am J Cardiol. 2005;96;1322-1327.
21. Muller-Hulsbeck S, Frahm C, Behm C, Schafer PJ, Bolte H, Heller M, et al. Low profile stent placement with the monorail technique for treatment of renal artery stenosis: Midterm results of a prospective trial. J Vasc Interv Radiol. 2005;16:963-971.
22. Galaria II, Surowiec SM, Rhodes JM, Illig KA, Shortelli CK, Sternbach Y, et al. Percutaneous and open renal revascularizations have equivalent long-term functional outcomes. Ann Vasc Surg. 2005;19:218-228.
23. Chabova V, Schirger A, Stanson A, McKusick MA, Textor SC. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc. 2000;75:437-444.
24. Losito A, Errico R, Santirosi P, Lupatteli T, Scalera GB, Lupatteli L. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant.2005;20:1604-1609.
25. Textor SC. Ischemic nephropathy: Where are we now? J Am Soc Nephrol. 2004;15:1974-1982.
26. Kaehler J, Tuleweit A, Steven D, Krempl T, Haar A, Carstensen M, et al. Association between eotaxin(CCL11), C-reactive protein, and antimicrobial antibodies in patients undergoing coronary angioplasty. J Investig Med. 2006;54:446-454.
27. Mosedale DE, Smith DJ, Aitken S, Schofield PM, Clarke SC, McNab D, et al. Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction. Atherosclerosis. 2005;183:268-274.
28. Meytier A. Atherosclerosis and the kidney. Nephrol Ther. 2005;1:183-202.
29. Textor SC, Wilcox CS. Renal artery stenosis: A common, treatable cause of renal failure? Annu Rev Med. 2001;52:421-442.
30. Johnson KJ, Weinberg JM. Postischemic renal injury due to oxygen radicals. Cuur Opin Nephrol Hypertens. 1993;2:625-635.